MIRD-237 is a pivotal document in the field of nuclear medicine, providing essential data and guidelines for the dosimetry of radiopharmaceuticals. Its impact extends to enhancing patient care, facilitating the development of new radiopharmaceuticals, and promoting a standardized approach to radiation dosimetry. As the field continues to evolve, the contributions of MIRD-237 and subsequent reports will remain vital for advancing the science and practice of nuclear medicine.
The Medical Internal Radiation Dose (MIRD) Committee Report No. 237 provides critical guidance on the use of internal radiation dosimetry in nuclear medicine. This report, published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), aims to update and expand the dosimetry data and methods available for radiopharmaceuticals used in both diagnostic and therapeutic applications. MIRD-237 focuses on standardizing and improving the accuracy of dose estimates for various radiopharmaceuticals, which is essential for ensuring patient safety and optimizing treatment outcomes.
The title associated with this code is roughly translated as "Rich Kiss and Sex That You Can’t Take Your Eyes Off Of."